13 December 2019 in Scientific Reports
Hepatocellular carcinoma (HCC) is one of the most common types of cancer worldwide. There are many factors in the etiology of HCC such as hepatitis B virus (HBV), hepatitis C virus (HCV), alcohol, obesity, smoking and aflatoxin. Many types of cancer are assumed to be associated with ABO blood group and Rhesus factor (RH). In this study we aimed to evaluate the relationship between tumor characteristics and overall survival (OS), ABO blood group and RH factor in patients with HCC. A total of 507 patients with chronic liver disease (252 patients with HCC and 255 patients without HCC) were included in the study. All demographic, clinic and laboratory (biochemical parameters and blood type) features were collected retrospectively. The mean age of the patients was 54.50 ± 9.30. There was no significant difference in both ABO groups and RH factors between the two groups. We found that vascular invasion rate of the tumor was higher in the B blood group and multicentric localization of tumor was significantly higer in patients with positive RH but there was no difference between OS in ABO and RH blood groups. In addition, the tumor was less multicentric in the AB blood group. Blood groups and RH factor can be used to predict the prognosis in cirrhotic patients with HCC.
1 January 2023 in Hepatology Forum
Background and Aim: Combined hepatocellular-cholangiocarcinoma (CHC) requires attention clinically and pathologically after liver transplantation (LT) because of its unique biology, difficulties in diagnosis, and being rare. We aimed to present our single center experience for this incidental combined tumor. It is aimed to present our single-center experience for this incidental combined tumor. Materials and Methods: Seventeen patients with CHC were included in the study. There were 260 hepatocellular carcinoma (HCC) patients determined as the control group. Patients were evaluated for demographic, etiological, pathological features, and survival. Results: Macrovascular and microvascular invasion levels were signifi-cantly higher in the CHC group (p
14 May 2025 in Annals of Transplantation
BACKGROUND Living donor liver transplantation (LDLT) faces increasing challenges due to the rising prevalence of hepatic steatosis among potential donors. Moderate steatosis (30-60%) is particularly problematic, often leading to donor exclusion and reducing the available donor pool. Preoperative interventions aiming to reduce hepatic fat content have emerged as a potential strategy, but data regarding their safety and efficacy remain limited. MATERIAL AND METHODS This retrospective, single-center study evaluated 34 living liver donors between June 2023 and August 2024. Fourteen donors received preoperative treatment for moderate hepatic steatosis, while 20 donors with mild or no steatosis served as controls. Pre- and post-treatment assessments included body mass index (BMI), liver fat assessment via computed tomography (CT), liver function tests, and perioperative outcomes. RESULTS Preoperative treatment significantly reduced hepatic fat content, with all treated donors achieving steatosis levels below 30% (P0.05). No donor experienced serious complications during the early postoperative period or the first year of follow-up. All donors maintained satisfactory graft and remnant liver function, and no treatment-related adverse events were observed. CONCLUSIONS Preoperative management of moderate hepatic steatosis in living liver donors is effective in reducing liver fat to acceptable levels without compromising donor safety. This approach offers a promising strategy to expand the LDLT donor pool. Further large-scale, multicenter studies with extended follow-up are necessary to validate these findings.
25 December 2019 in Akademik Gastroenteroloji Dergisi
Giriş ve Amaç: Bu çalışmanın amacı kronik hepatit B’ye bağlı siroz hastalarında, hepatosellüler karsinom gelişimini etkileyen faktörlerin değerlendirilmesidir. Gereç ve Yöntem: Ocak 2010 - Ocak 2019 yılları arasında Demiroğlu Bilim Üniversitesi Tıp Fakültesi gastroenteroloji polikliniğinde hepatit B virüsüne bağlı karaciğer sirozu nedeniyle takip edilen 18 yaş üstü 324 hasta çalışmaya dahil edildi. Olguların demografik (yaş, cinsiyet), beden kitle indeksi, laboratuvar [biyokimyasal ve serolojik parametreler (hepatit B yüzey antijeni, hepatit b virüs-DNA)], görüntüleme ve biyopsi sonuçları hastane bilgi sisteminden retrospektif olarak toplandı. Hastalar hepatosellüler karsinom ve non- hepatosellüler karsinom olarak iki gruba ayrıldı. Bulgular: Çalışmaya dahil edilen hastaların 114’ü hepatosellüler karsinom ve 210’u ise non- hepatosellüler karsinom sirozlu idi. Hastaların yaş ortalaması 54.50±9.30 idi. Hepatosellüler karsinom ile non-hepatosellüler karsinom grupları karşılaştırıldığında yaş ortalaması, Homeostatic Model of Assessment Insulin Resistance, hepatit B virüs-DNA ve alfa fetoprotein değerleri hepatosellüler karsinom grubunda istatistiksel olarak daha yüksek saptandı. Asit, özofagus varis kanaması ve hepatik ensefalopati non-hepatosellüler karsinom grubunda daha yüksek oranda görülürken, spontan bakteriyel peritonit ise hepatosellüler karsinom grubunda istatistiksel olarak daha yüksek oranda bulundu. Hepatosellüler karsinom oluşumunu öngörebilecek bağımsız risk faktörleri incelendiğinde, alfa fetoprotein ve hepatit B virüs-DNA değerlerinin istatistiksel olarak bağımsız risk faktörü olduğu görüldü (sırasıyla; p=0.001 ve p=0.037). Sonuç: Çalışmamızda hepatit B virüsüne bağlı siroz hastalarında hepatosellüler karsinom için alfa fetoprotein ve hepatit B virüs-DNA değerleri bağımsız risk faktörü olarak saptandı. Alfa fetoprotein ve hepatit B virüs-DNA değerleri hepatit B virüsüne bağlı siroz hastalarında hepatosellüler karsinom gelişiminde kullanışlı birer belirteç olabilir.
24 August 2023 in Acibadem Universitesi Saglik Bilimleri Dergisi
Background/Purpose: Hepatocellular cancer constitutes 75-85% of liver cancers, and its treatment requires a multidisciplinary approach. Milan criteria are golden standart candidate selection criteria that ensure excellent posttransplant survival and follow up with low recurrence rate. However, other classifications include histopathological features or biological behaviors may vary survival and recurrence. We examined the parameters that may have prognostic value in out study. Methods: 217 patients for recurrence, 226 patients for overall survival, 48 patients for disease free survival, whose explant pathology is hepatocellular carcinoma and data information can be obtained were evaluated. Recurrence and overall survival and disease free survival were statistically analyzed in terms of age, gender, living and cadaveric transplanted patient groups, blood group, BMİ, MELD and Child scores, milan criteria and pathological parameters. All survival rates were evaluated in terms of recurrent organ location, number of organ recurrence, and survival rates. Results: There were less recurrence rates in patients, with 0 blood group, inside milan, with less total and maximum tumor diameter. It was also observed that the maximum tumor size affected the overall survival multivariately It was observed that survival was worse in early recurrence and recurrence in the first 24 months. Conclusion: İt is observed that being inside the milan and tumor diameter affect the recurrence and survival, surgery to be performed in localized recurrences and additional systemic treatment will affect survival positively.
29 October 2024 in DAHUDER Medical Journal
Objectives: Hepatic cirrhosis is a disease with high mortality. The leading causes of morbidity and mortality in patients with hepatic cirrhosis are disease-associated complications. We aimed to describe the association between the difference in laboratory parameters, complications, and commonly known causes of cirrhosis, such as hepatitis B, hepatitis C, alcoholic liver disease (NASH), and autoimmune hepatitis. Methods: We investigated 541 patients with different etiologies of cirrhosis who applied to a gastroenterology clinic from 2009 to 2018 in Florance Nightingale Hospital. All patients were divided into five groups according to the etiology of cirrhosis, such as hepatitis B, hepatitis C, alcoholic liver disease (ALD), NASH, and autoimmune hepatitis. Biochemical and metabolic parameters were evaluated between five groups. Results: 83 patients with alcoholic liver disease, 242 patients with hepatitis B-associated cirrhosis, 112 patients with hepatitis C-associated cirrhosis, 77 patients with NASH, and 27 patients with autoimmune hepatitis were enrolled. Laboratory parameters due to the etiology of hepatic cirrhosis are shown in Table 2. Ascites and hepatic encephalopathy were statistically higher in alcoholic liver disease, hepatitis B, and NASH cirrhosis, while esophageal variceal bleeding was higher in NASH and autoimmune hepatitis. Spontaneous bacterial peritonitis was statistically higher only in cirrhosis due to autoimmune hepatitis. Conclusion: It is very important to assign complications that may develop in liver cirrhosis and manage them by etiology.